Skip to main content

Advertisement

SpringerLink
Log in

The role of capillaroscopy in differentiation of primary and secondary Raynaud’s phenomenon in rheumatic diseases: a review of the literature and two case reports

  • Review
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

The purpose of this study is to study and systematize the current knowledge about the role of capillaroscopy in differentiation of primary and secondary Raynaud’s phenomenon (RP) in rheumatic diseases. This method is a review of the literature. Capillaroscopy is of crucial value for diagnosis and differentiation of primary and secondary RP in rheumatic diseases. The appearance of abnormal capillaroscopic pattern inherits high positive predictive value for the development of systemic rheumatic disease. The most specific pattern is found in systemic sclerosis (SSc), so called “scleroderma pattern”, which is characterized by the presence of dilated capillaries, hemorrhages, avascular areas and neoangiogeneis. It is found in more than 90% of patients with overt SSc. Similar changes are found in patients with dermatomyositis, mixed connective tissue disease, undifferentiated connective tissue disease and they are called “scleroderma-like pattern”. Absence of abnormal capillaroscopic findings can be regarded as a diagnostic criterion for primary RP. Inclusion of pathologic capillaroscopic pattern may increase the sensitivity of ACR classification criteria for SSc. In conclusion, capillaroscopy is of crucial importance for the differentiation of primary and secondary RP in rheumatic diseases, and also in differentiation between different forms of connective tissue diseases as well as for their early diagnosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Cortes S, Cutolo M (2007) Capillaroscopic patterns in rheumatic diseases. Acta Rheumatol Port 32:29–36

    Google Scholar 

  2. Shore AC (2000) Capillaroscopy and measurement of capillary pressure. Br J Clin Pharmacol 50(6):501–513. doi:10.1046/j.1365-2125.2000.00278.x

    Article  PubMed  CAS  Google Scholar 

  3. Grassi W, De Anglis R (2007) Capillaroscopy: questions and answers. Clin Rheumatol 26:2009–2016. doi:10.1007/s10067-007-0681-3

    Article  PubMed  Google Scholar 

  4. Ulf Müller-Ladner (2008) Raynaud’s phenomenon and peripheral ischemic syndromes, 1st edn. UNI-MED Verlag AG, Bremen

    Google Scholar 

  5. Maricq HR, LeRoy EC, D’Angelo WA et al (1980) Diagnostic potential of in vivo capillary microscopy in scleroderma and related disorders. Arthritis Rheum 23(2):183–189. doi:10.1002/art.1780230208

    Article  PubMed  CAS  Google Scholar 

  6. Bollinger A, Fagrell B (1990) Clinical capillaroscopy—a guide to its use in clinical research and practice. Hogrete&Huber Publishers, Toronto, Ontario, pp 1–158

    Google Scholar 

  7. Bergman R, Sharony L, Schapira D et al (2003) The handheld dermatoscope as a nail-foiled capillaroscopic instrument. Arch Dermatol 139:1027–1030. doi:10.1001/archderm.139.8.1027

    Article  PubMed  Google Scholar 

  8. Cutolo M, Grassi W, Matucci Cerinic M (2003) Raynaud’s phenomenon ant the role of capillaroscopy. Arthritis Rheum 48(11):3023–3030. doi:10.1002/art.11310

    Article  PubMed  Google Scholar 

  9. Cutolo M, Sulli A, Pizzorni C, Accardo S (2000) Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis. J Rheumatol 27:155–160

    PubMed  CAS  Google Scholar 

  10. Cutolo M, Pizzorni C, Tuccio M et al (2004) Nailfold videocapillaroscopic patterns and serum autoantibodies in systemic sclerosis. Rheumatol 43:719–726. doi:10.1093/rheumatology/keh156

    Article  CAS  Google Scholar 

  11. Cutolo M, Pizzorni C, Sulli A (2005) Capillaroscopy. Best Pract Res Clin Rheumatol 19(3):437–452. doi:10.1016/j.berh.2005.01.001

    Article  PubMed  Google Scholar 

  12. Cutolo M, Sulli A, Secchi ME et al (2007) The contribution of capillaroscopy to the differential diagnosis of connective autoimmune diseases. Best Pract Res Clin Rheumatol 21(6):1093–1108. doi:10.1016/j.berh.2007.10.001

    Article  PubMed  Google Scholar 

  13. Bredemeier M, Xavier RM, Capobianco KG et al (2004) Nailfold capillary microscopy can suggest pulmonary disease activity in systemic sclerosis. J Rheumatol 31:286–294

    PubMed  Google Scholar 

  14. Dolezalova P, Young SP, Bacon PA, Southwood TR (2003) Nailfold capillary microscopy in healthy children and in childhood rheumatic diseases: a prospective single blind observational study. Ann Rheum Dis 62(5):444–449. doi:10.1136/ard.62.5.444

    Article  PubMed  CAS  Google Scholar 

  15. Kabasakal Y, Elvins DM, Ring EF, McHugh NJ (1996) Quantitative nailfold capillaroscopy findings in a population with connective tissue disease and in normal healthy controls. Ann Rheum Dis 55:507–512. doi:10.1136/ard.55.8.507

    Article  PubMed  CAS  Google Scholar 

  16. Lee P, Leung FY, Alderdice C, Armstrong SK (1983) Nailfold capillary microscopy in the connective tissue diseases: a semiquantitative assessment. J Rheumatol 10(6):930–938

    PubMed  CAS  Google Scholar 

  17. Lefford F, Edwards JCW (1986) Nailfold capillary microscopy in connective tissue disease: a quantitative morphological analysis. Ann Rheum Dis 45:741–749. doi:10.1136/ard.45.9.741

    Article  PubMed  CAS  Google Scholar 

  18. Maricq HR, Harper FE, Khan MM et al (1983) Microvascular abnormalities as possible predictors of disease subsets in Raynaud phenomenon and early connective tissue disease. Clin Exp Rheumatol 1(3):195–205

    PubMed  CAS  Google Scholar 

  19. Maricq HR (1986) Comparison of quantitative and semiquantitative estimates of nailfold capillary abnormalities in scleroderma spectrum disorders. Microvasc Res 32(2):271–276. doi:10.1016/0026-2862(86)90062-2

    Article  PubMed  CAS  Google Scholar 

  20. Redisch W (1970) Capillaroscopic observations in rheumatic diseases. Ann Rheum Dis 29:244–253. doi:10.1136/ard.29.3.244

    Article  PubMed  CAS  Google Scholar 

  21. Anders HJ, Sigl T, Schattenkirchner M (2001) Differentiation between primary and secondary Raynaud’s phenomenon: a prospective study comparing nailfold capillaroscopy using an ophthalmoscope or stereomicroscope. Ann Rheum Dis 60:407–409. doi:10.1136/ard.60.4.407

    Article  PubMed  CAS  Google Scholar 

  22. Beltran E, Toll A, Pros A et al (2007) Assessment of nailfold capillaroscopy by ×30 digital epiluminescence (dermoscopy) in patients with Raynaud’s phenomenon. Clin Lab Invest 156:892–898

    CAS  Google Scholar 

  23. Anderson ME, Allen PD, Moore T et al (2005) Computerized nailfold videocapillaroscopy–a new tool for assessment of Raynaud’s phenomenon. J Rheumatol 32:841–848

    PubMed  Google Scholar 

  24. Herrick AL (2008) Diagnosis and management of scleroderma peripheral vascular disease. Rheum Dis Clin North Am 34:89–114. doi:10.1016/j.rdc.2007.11.006

    Article  PubMed  Google Scholar 

  25. Ho M, Belch JJF (1998) Raynaud’s phenomenon: State of the Art 1998. Scand J Rheumatol 27:319–322. doi:10.1080/03009749850154311

    Article  PubMed  CAS  Google Scholar 

  26. Cutolo M, Sulli A, Secchi ME et al (2006) Nailfold capillaroscopy is useful for the diagnosis and follow-up of autoimmune rheumatic diseases. A future tool for the analysis of microvascular heart involvement? Rheumatol 45:43–46. doi:10.1093/rheumatology/kel310

    Article  Google Scholar 

  27. Herrick AL, Clark S (1998) Quantifying digital vascular disease in patients with primary Raynaud’s phenomenon and systemic sclerosis. Ann Rheum Dis 57:70–78

    Article  PubMed  CAS  Google Scholar 

  28. Block JA, Sequeira W (2001) Raynaud’s phenomenon. Sem Lancet 357:2042–2048. doi:10.1016/S0140-6736(00)05118-7

    Article  CAS  Google Scholar 

  29. Seibold JR, Steen VD (1994) Systemic sclerosis. In: Klippel JH, Dieppe PA (eds) Rheumatology. London, Mosby, pp 6.8–6.11

  30. Steven AO (2001) Raynaud’s phenomenon. In: Sterling JB (ed) Secrets of rheumatology. Binom, Moscow, pp 614–619

  31. Susol E, MacGregor AJ, Barrett JH et al (2000) A two- stage, genome-wide screen for susceptibility loci in primary Raynaud’s phenomenon. Arthritis Rheum 43(7):1641–1646. doi:10.1002/1529-0131(200007)43:7<1641::AID-ANR30>3.0.CO;2-Y

    Article  PubMed  CAS  Google Scholar 

  32. Le Roy EC, Medsger TA Jr (1992) Raynaud’s phenomenon–a proposal for classification. Clin Exp Rheumatol 10:485–488

    CAS  Google Scholar 

  33. Bukhari M, Hollis S, Moore T et al (2000) Quantitation of microcirculatory abnormalities in patients with primary Raynaud’s phenomenon and systemic sclerosis by videocapillaroscopy. Rheumatol 39(5):506–512. doi:10.1093/rheumatology/39.5.506

    Article  CAS  Google Scholar 

  34. Nagy Z, Czirjac L (2004) Nailfold digital capillaroscopy in 447 patients with connective tissue disease and Raynaud` disease. J Eur Acad Dermatol Venereol 18:62–68. doi:10.1111/j.1468-3083.2004.00853.x

    Article  PubMed  CAS  Google Scholar 

  35. Blockmans D, Beyens G, Verhaeghe R (1996) Predictive value of nailfold capillaroscopy in the diagnosis of connective tissue diseases. Clin Rheumatol 15(2):148–153. doi:10.1007/BF02230332

    Article  PubMed  CAS  Google Scholar 

  36. Pavlov-Dolijanovic S, Damjanov N, Ostojić P et al (2006) The prognostic value of nailfold capillary changes for the development of connective tissue disease in children and adolescents with primary Raynaud’s phenomenon: a follow-up study of 250 patients. Pediatr Dermatol 23(5):437–442. doi:10.1111/j.1525-1470.2006.00278.x

    Article  PubMed  Google Scholar 

  37. Ziegler S, Brunner M, Eigenbauer E, Minar E (2003) Long-term outcome of primary Raynaud’s phenomenon and its conversion to connective tissue disease: a 12-year prospective patient analysis. Scand J Rheumatol 32:343–347. doi:10.1080/03009740410005007

    Article  PubMed  CAS  Google Scholar 

  38. Kirou KA, Crow MK (2000) Raynaud’s phenomenon. In: Paget SA et al (eds) Manual of rheumatology and outpatient orthopedic disorders: diagnosis and therapy, 4th edn. Lippincot Williams & Willkins, Philadelphia, pp 82–87

    Google Scholar 

  39. Ling SM, Wigley FM (1999) Raynaud’s phenomenon in older adults. Diagnostic considerations and management. Drugs Aging 15(3):183–195. doi:10.2165/00002512-199915030-00002

    Article  PubMed  CAS  Google Scholar 

  40. Sherber NS, Wigley FM, Scher R (2007) Autoimmune disorders: nail signs and therapeutic approaches. Dermatol Ther 20(1):17–30. doi:10.1111/j.1529-8019.2007.00108.x

    Article  PubMed  Google Scholar 

  41. Silver RM (2005) Systemic sclerosis and scleroderma variants:clinical aspects. In: Koopman WJ et al (eds) Arthritis and allied conditions, 15th edn. Lippincot Williams &Wilkins, Philadelphia, pp 1633–1680

    Google Scholar 

  42. Mulligan-Kehoe MJ, Simons M (2008) Vascular disease in scleroderma: angiogenesis and vascular repair. Rheum Dis Clin North Am 34:73–79. doi:10.1016/j.rdc.2007.12.006

    Article  PubMed  Google Scholar 

  43. Caramaschi P, Canestrini S, Martinelli N et al (2007) Scleroderma patients nailfold videocapillaroscopic patterns are associated with disease subset and disease severity. Rheumatol 46(10):1566–1569. doi:10.1093/rheumatology/kem190

    Article  CAS  Google Scholar 

  44. Houtman PM, Kallenberg CG, Wouda AA, The TH (1985) Decreased nailfold capillary density in Raynaud’s phenomenon: a reflection of immunologically mediated local and systemic vascular disease? Ann Rheum Dis 44:603–609. doi:10.1136/ard.44.9.603

    Article  PubMed  CAS  Google Scholar 

  45. Ostojic P, Damjanov N (2006) Different clinical features in patients with limited and diffuse cutaneous systemic sclerosis. Clin Rheumatol 25:453–457. doi:10.1007/s10067-005-0041-0

    Article  PubMed  Google Scholar 

  46. Lovy M, MacCarter D, Steigerwald JC (1985) Relationship between nailfold capillary abnormalities and organ involvement in systemic sclerosis. Arthritis Rheum 28(5):496–501. doi:10.1002/art.1780280505

    Article  PubMed  CAS  Google Scholar 

  47. Masi A, Rodnan GP, Medsger TA et al (1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 23:581–590. doi:10.1002/art.1780230510

    Article  Google Scholar 

  48. Lonzetti LS, Joyal F, Raynauld JP et al (2001) Updating the American College of Rheumatology preliminary classification criteria for systemic sclerosis: addition of severe nailfold capillaroscopy abnormalities markedly increases the sensitivity for limited scleroderma. Arthritis Rheum 44(3):735–736. doi:10.1002/1529-0131(200103)44:3<735::AID-ANR125>3.0.CO;2-F

    Article  PubMed  CAS  Google Scholar 

  49. Walker JG (2007) The development of systemic sclerosis classification criteria. Clin Rheumatol 26:1401–1409. doi:10.1007/s10067-007-0537-x

    Article  PubMed  Google Scholar 

  50. Hudson M, Taillefer S, Steele R et al (2007) Improving the sensitivity of the American College of Rheumatology classification criteria for systemic sclerosis. Clin Exp Rheumatol 25(5):754–757

    PubMed  CAS  Google Scholar 

  51. Le Roy EC, Medsger TA Jr (2001) Criteria for the classification of early systemic sclerosis. J Rheumatol 28:573–576

    Google Scholar 

  52. Maricq HR, Valter I (2004) A working classification of scleroderma spectrum disorders: a proposal and the results of testing on a sample of patients. Clin Exp Rheumatol 22(3)(Suppl 33):S5–S13

    Google Scholar 

  53. Nadashkevich O, Davis P, Fritzler MJ (2004) A proposal of criteria for the classification of systemic sclerosis. Med Sci Monit 10(11):CR615–CR621

    PubMed  Google Scholar 

  54. Granier F, Priollet P, Housset E (1986) Nailfold capillary microscopy in mixed connectivetissue disease. Comparison with systemic sclerosis and systemic lupus erythematosus. Arthritis Rheum 29(2):189–195. doi:10.1002/art.1780290206

    Article  PubMed  CAS  Google Scholar 

  55. Furtado RNV, Pucinelli ML, Cristo VV et al (2002) Scleroderma-like nailfold capillaroscopic abnormalities are associated with anti-U1-RNP antibodies and Raynaud’s phenomenon in SLE patients. Lupus 11(1):35–41. doi:10.1191/0961203302lu144oa

    Article  PubMed  CAS  Google Scholar 

  56. Groen H, ter Borg EJ, Postma DS et al (1992) Pulmonary function in systemic lupus erythematosus is related to distinct clinical, serologic, and nailfold capillary patterns. Am J Med 93(6):619–627. doi:10.1016/0002-9343(92)90194-G

    Article  PubMed  CAS  Google Scholar 

  57. Ingegnoli F, Zeni S, Meani L et al (2005) Evaluation of nailfold videocapillaroscopic abnormalities in patients with systemic lupus erythematosus. J Clin Rheumatol 11(6):295–298. doi:10.1097/01.rhu.0000191193.93720.95

    Article  PubMed  Google Scholar 

  58. Bongard O, Bounameaux H, Miescher PA, De Moerloose P (1995) Association of anticardiolipin antibodies and abnormal nailfold capillaroscopy in patients with systemic lupus erythematosus. Lupus 4(2):142–144. doi:10.1177/096120339500400211

    Article  PubMed  CAS  Google Scholar 

  59. Riccieri V, Spadaro A, Ceccarelli F et al (2005) Nailfold capillaroscopy changes in systemic lupus erythematosus: correlation with disease activity and autoantibody profile. Lupus 14:521–525. doi:10.1191/0961203305lu2151oa

    Article  PubMed  CAS  Google Scholar 

  60. Asherson RA, Pierangeli SS, Cervera R (2007) Is there a microangiopathic antiphospholipid syndrome? Ann Rheum Dis 66:429–432. doi:10.1136/ard.2006.067033

    Article  PubMed  CAS  Google Scholar 

  61. Pallis M, Hopkinson N, Powell R (1991) Nailfold capillary density as a possible indicator of pulmonary capillary loss in systemic lupus erythematosus but not in mixed connective tissue disease. J Rheumatol 18(10):1532–1536

    PubMed  CAS  Google Scholar 

  62. Ganczarczyk ML, Lee Armstrong SK (1988) Nailfold capillary microscopy in polymyositis and dermatomyositis. Arthritis Rheum 31(1):116–119. doi:10.1002/art.1780310116

    Article  PubMed  CAS  Google Scholar 

  63. Nascif AK, Terreri MT, Len CA et al (2006) Inflammatory myopathies in childhood: correlation between nailfold capillaroscopy findings and clinical and laboratory data. J Pediatr 82:40–45. doi:10.2223/JPED.1435

    Article  Google Scholar 

  64. Smolen JS, Steiner G (1998) Mixed connective tissue disease: to be or not to be? Arthritis Rheum 41(5):768–777. doi:10.1002/1529-0131(199805)41:5<768::AID-ART3>3.0.CO;2-Z

    Article  PubMed  CAS  Google Scholar 

  65. de Holanda Mafaldo Diógenes A, Bonfá E, Fuller R, Correia Caleiro MT (2007) Capillaroscopy is a dynamic process in mixed connective tissue disease. Lupus 16(4):254–258. doi:10.1177/0961203307076517

    Article  PubMed  Google Scholar 

  66. Garcia-Carrasco M, Sisó A, Ramos-Casals M et al (2002) Raynaud’s phenomenon in primary Sjogren’s syndrome. Prevalence and clinical characteristics in a series of 320 patients. J Rheumatol 29:726–730

    PubMed  Google Scholar 

  67. Tektonidou M, Kaskani E, Skopouli FN, Moutsopoulos HM (1999) Microvascular abnormalities in SjÖgren’s syndrome: nailfold capillaroscopy. Rheumatol 38:826–830. doi:10.1093/rheumatology/38.9.826

    Article  CAS  Google Scholar 

  68. Capobianco KG, Xavier RM, Bredemeier M et al (2005) Nailfold capillaroscopic findings in primary Sjögren’s syndrome: clinical and serological correlations. Clin Exp Rheumatol 23(6):789–794

    PubMed  CAS  Google Scholar 

  69. Aguiar T, Furtado E, Dorigo D et al (2006) Nailfold videocapillaroscopy in primary SjÖgren’s syndrome. Angiology 57(5):593–599. doi:10.1177/0003319706293127

    Article  PubMed  Google Scholar 

  70. Carrol GJ, Withers K, Bayliss CE (1981) The prevalence of Raynaud’s syndrome in rheumatoid arthritis. Ann Rheum Dis 40:567–570. doi:10.1136/ard.40.6.567

    Article  Google Scholar 

  71. Grassi W, Blasetti P, Core P, Cervini C (1994) Raynaud’s phenomenon in rheumatoid arthritis. Br J Rheumatol 33:139–141. doi:10.1093/rheumatology/33.2.139

    Article  PubMed  CAS  Google Scholar 

  72. Saraux A, Allain J, Guedes C et al (1996) Raynaud’s phenomenon in rheumatoid arthritis. Br J Rheumatol 35(8):752–754. doi:10.1093/rheumatology/35.8.752

    Article  PubMed  CAS  Google Scholar 

  73. Grassi W, Felder M, Thüring-Vollenweider U, Bollinger A (1989) Microvascular dynamics at the nailfold in rheumatoid arthritis. Clin Exp Rheumatol 7(1):47–53

    PubMed  CAS  Google Scholar 

  74. Bhushan M, Moore T, Herrick AL, Griffiths CE (2000) Nailfold video capillaroscopy in psoriasis. Br J Dermatol 142:1171–1176. doi:10.1046/j.1365-2133.2000.03544.x

    Article  PubMed  CAS  Google Scholar 

  75. Salli L, Raimondi F, Pappalardo A (1999) Periungual capillaroscopy in psoriatic arthritis. Clin Term 150(6):409–412 Abstract

    CAS  Google Scholar 

  76. Vaz JL, Dancour MA, Bottino DA, Bouskela E (2004) Nailfold videocapillaroscopy in primary antiphospholipid syndrome. Rheumatol 43:1025–1027. doi:10.1093/rheumatology/keh233

    Article  CAS  Google Scholar 

  77. Filaci G, Cutolo M, Basso M et al (2001) Long-term treatment of patients affected by systemic sclerosis with cyclosporin A. Rheumatology 40(12):1431–1432. doi:10.1093/rheumatology/40.12.1431 letter

    Article  PubMed  CAS  Google Scholar 

  78. Hahn M, Klyscz T, Jünger M, Rassner G (1995) Local cold exposure test as therapy control in patients with Raynaud’s phenomenon: comparison between laser Doppler fluxmetry and simultaneous red blood cell velocity measurements in nailfold capillaries. Br J Dermatol 133(5):704–709

    Article  PubMed  CAS  Google Scholar 

  79. Schlez A, Häfner HM, Kittel M et al (2003) Systemic scleroderma patients have improved skin perfusion after the transdermal application of PGE1 ethyl ester. Vasa 32(2):83–86. doi:10.1024/0301-1526.32.2.83

    Article  PubMed  CAS  Google Scholar 

  80. Combe B, Landewe R, Lukas C et al (2007) EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 66:34–45. doi:10.1136/ard.2005.044354

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medical University, Clinic of Rheumatology, Plovdiv, Bulgaria

    Sevdalina Nikolova Lambova

  2. Department for Internal Medicine and Rheumatology, Justus-Liebig University Giessen, Giessen, Germany

    Ulf Müller-Ladner

  3. Department for Rheumatology and Clinical Immunology, Kerckhoff Clinic, Bad Nauheim, Germany

    Ulf Müller-Ladner

Authors
  1. Sevdalina Nikolova Lambova
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ulf Müller-Ladner
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sevdalina Nikolova Lambova.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lambova, S.N., Müller-Ladner, U. The role of capillaroscopy in differentiation of primary and secondary Raynaud’s phenomenon in rheumatic diseases: a review of the literature and two case reports. Rheumatol Int 29, 1263–1271 (2009). https://doi.org/10.1007/s00296-009-1019-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-009-1019-z

Keywords

Search

Navigation